Log in
FREE 15-Day Trial
Intelligent Investor
Intelligent Investor
  1. Home
  2. Research & Advice
  3. Research Tools
  4. Shares
  5. Antisense Therapeutics Limited (ANP)
  6. Company Announcements

Antisense Therapeutics Limited (ASX: ANP) - Announcements

Current share price for ANP : $0.058 0.003 (4.92%)

ASX company news and announcements for Antisense Therapeutics Limited (ANP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Antisense Therapeutics Limited (ANP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Antisense Therapeutics Limited (ANP), please use our Company Announcements tool to search across all ASX-listed companies.

Intelligent Investor free trial for buy hold sell stock recommendations

Latest company announcements for Antisense Therapeutics Limited (ANP)

Search all Announcements
Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg		 Gain/Loss
$52 Receipt of R&D Tax Incentive Payment 23 Feb 2023 9:11AM $0.100 $0.058 $0.059 fallen by 42%
$52 Half Yearly Report and Accounts 22 Feb 2023 4:24PM $0.100 $0.058 $0.059 fallen by 42%
$52 Presentation at International Conference on DMD 17 Feb 2023 9:42AM $0.097 $0.058 $0.059 fallen by 40.21%
$52 First approval for ATL1102 Phase IIb DMD clinical trial 14 Feb 2023 8:46AM $0.096 $0.058 $0.059 fallen by 39.58%
$52 Limb Girdle Muscular Dystrophy R2 animal study commenced 13 Feb 2023 9:46AM $0.090 $0.058 $0.059 fallen by 35.56%
$52 Positive outcomes in DMD combination therapy animal study 1 Feb 2023 9:54AM $0.082 $0.058 $0.059 fallen by 29.27%
$52 Quarterly Activities/Appendix 4C Cash Flow Report 25 Jan 2023 9:45AM $0.088 $0.058 $0.059 fallen by 34.09%
$52 Notification regarding unquoted securities - ANP 21 Dec 2022 5:05PM $0.090 $0.058 $0.059 fallen by 35.20%
$52 Phase IIb DMD CTA submitted for trial conduct in Europe 19 Dec 2022 9:35AM $0.086 $0.058 $0.059 fallen by 32.56%
$52 Application for quotation of securities - ANP 23 Nov 2022 5:47PM $0.099 $0.058 $0.059 fallen by 41.41%
$52 Final Director's Interest Notice (GWP) 22 Nov 2022 9:25AM $0.091 $0.058 $0.059 fallen by 36.26%
$52 Results of Annual General Meeting 17 Nov 2022 4:14PM $0.098 $0.058 $0.059 fallen by 40.82%
$52 AGM Presentation 17 Nov 2022 1:45PM $0.100 $0.058 $0.059 fallen by 42%
$52 Antisense Therapeutics CEO announces retirement 15 Nov 2022 9:21AM $0.110 $0.058 $0.059 fallen by 47.27%
$52 ATL1102 tox study to support clinical program in the US 14 Nov 2022 9:23AM $0.100 $0.058 $0.059 fallen by 42%
$52 Change of Registry Address 31 Oct 2022 4:04PM $0.082 $0.058 $0.059 fallen by 29.27%
$52 Quarterly Activities/Appendix 4C Cash Flow Report 26 Oct 2022 2:07PM $0.086 $0.058 $0.059 fallen by 32.56%
$52 Appendix 4G 19 Oct 2022 9:14AM $0.086 $0.058 $0.059 fallen by 32.56%
$52 Corporate Governance Statement 19 Oct 2022 9:12AM $0.086 $0.058 $0.059 fallen by 32.56%
$52 Annual Report 19 Oct 2022 9:10AM $0.086 $0.058 $0.059 fallen by 32.56%
$52 Notice of Annual General Meeting 19 Oct 2022 9:08AM $0.086 $0.058 $0.059 fallen by 32.56%
$52 Non-Executive Director Retirement 14 Oct 2022 4:17PM $0.087 $0.058 $0.059 fallen by 33.33%
$52 Receipt of further R&D Tax Incentive Payment 14 Oct 2022 8:20AM $0.092 $0.058 $0.059 fallen by 36.96%
$52 Change of Director's Interest Notice (GP) 7 Oct 2022 4:05PM $0.086 $0.058 $0.059 fallen by 32.56%
$52 Company Appointment Chief Commercial Officer 5 Oct 2022 9:32AM $0.083 $0.058 $0.059 fallen by 30.12%

51 - 75 of 707 results

Page 3 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.